Insulinoma: Clinical Trials

3 trials for Insulinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Unknown 3

Follow Insulinoma: new trials by email Literature Review of Insulinoma trials Research Report on Insulinoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
[68Ga]Ga-HBED-CC-exendin-4, [68Ga]Ga-NOTA-exendin-4 - Insulinoma
Early Phase 1UnknownPeking Union Medical College Hospital202021-10-012022-10-14
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
68Ga-NOTA-MAL-Cys39-exendin-4 - Insulinoma
Early Phase 1UnknownNanjing First Hospital, Nanjing Medical University602019-05-052019-12-04
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
68Ga-NOTA-exendin-4 - Insulinoma, Nesidioblastosis
Early Phase 1UnknownPeking Union Medical College Hospital1002014-02-012015-09-25

Narrower conditions

Nesidioblastosis (1)

Broader conditions

Adenoma (3)  ·  Adenoma, Islet Cell (3)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Pancreatic Diseases (3)  ·  Pancreatic Neoplasms (3)  ·  Congenital Hyperinsulinism (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Glucose Metabolism Disorders (1)

Interventions

68Ga-NOTA-exendin-4 (1)

Sponsors

Peking Union Medical College Hospital (2)  ·  Nanjing First Hospital, Nanjing Medical University (1)

Countries

China (3)

Top investigators

Fang Li, MD (1)  ·  Feng Wang, Ph.D (1)  ·  Zhaohui Zhu, MD (1)

Results publications

PMID 39499011

NIH funding

ZIAEB000073 (1)